BIOMAT Database Logo BIOMAT Database Logo

Clinical effectiveness of niludipine in patients with ischemic heart disease. 1982

K Ogawa, and T Ito, and M Ban, and H Hashimoto, and K Nizoe, and M Mochizuki, and K Sakai, and J Watanabe, and H Kanayama, and K Okumura, and T Sone, and K Imura, and T Uno, and M Shikano, and K Kotaka, and Y Miyazaki

The antianginal efficacy of niludipine (Bay a 7167), a new calcium antagonistic drug, was investigated in 51 patients with ischemic heart disease. 16 patients were diagnosed as effort angina and 31 patients had both angina at rest and on effort. Six anginal patients had myocardial infarction. One patient was diagnosed as a variant form of angina and 3 others as unstable angina. 11 patients had essential hypertension. 49 completed the study and 2 dropped out. Niludipine (60 mg to 80 mg every 24 h) significantly reduced the mean weekly rate of angina attacks from 6.5 to 2.2 (p less than 0.001). Marked reductions of nitroglycerin requirement were also noted (p less than 0.001). In 71% of the patients complete control of anginal attacks was achieved, and in over 77% the frequency of angina was reduced by at least 50%. Niludipine was at 93.8% effective in patients with ischemic heart disease. It decreased significantly both systolic and diastolic blood pressure in angina patients with essential hypertension, but there were no significant changes of blood pressure in normotensive anginal patients. The agent was tolerated very well and there were no side effects. These findings suggest that niludipine is a highly effective drug for the treatment of both ischemic heart disease and essential hypertension.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Ogawa, and T Ito, and M Ban, and H Hashimoto, and K Nizoe, and M Mochizuki, and K Sakai, and J Watanabe, and H Kanayama, and K Okumura, and T Sone, and K Imura, and T Uno, and M Shikano, and K Kotaka, and Y Miyazaki
[Clinical effectiveness of depot nitroglycerin preparations in ischemic heart disease patients].
January 1984, Terapevticheskii arkhiv,
K Ogawa, and T Ito, and M Ban, and H Hashimoto, and K Nizoe, and M Mochizuki, and K Sakai, and J Watanabe, and H Kanayama, and K Okumura, and T Sone, and K Imura, and T Uno, and M Shikano, and K Kotaka, and Y Miyazaki
[Clinical effectiveness of palpitin in treating heart rhythm disorders in ischemic heart disease patients].
May 1987, Kardiologiia,
K Ogawa, and T Ito, and M Ban, and H Hashimoto, and K Nizoe, and M Mochizuki, and K Sakai, and J Watanabe, and H Kanayama, and K Okumura, and T Sone, and K Imura, and T Uno, and M Shikano, and K Kotaka, and Y Miyazaki
[Effectiveness of inosine derivatives in patients with ischemic heart disease].
August 1977, Vrachebnoe delo,
K Ogawa, and T Ito, and M Ban, and H Hashimoto, and K Nizoe, and M Mochizuki, and K Sakai, and J Watanabe, and H Kanayama, and K Okumura, and T Sone, and K Imura, and T Uno, and M Shikano, and K Kotaka, and Y Miyazaki
[Effectiveness of manual therapy in rehabilitating patients with ischemic heart disease].
January 2001, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
K Ogawa, and T Ito, and M Ban, and H Hashimoto, and K Nizoe, and M Mochizuki, and K Sakai, and J Watanabe, and H Kanayama, and K Okumura, and T Sone, and K Imura, and T Uno, and M Shikano, and K Kotaka, and Y Miyazaki
[Factors determining clinical effectiveness of clopidogrel and prognosis of patients with stable ischemic heart disease].
January 2011, Kardiologiia,
K Ogawa, and T Ito, and M Ban, and H Hashimoto, and K Nizoe, and M Mochizuki, and K Sakai, and J Watanabe, and H Kanayama, and K Okumura, and T Sone, and K Imura, and T Uno, and M Shikano, and K Kotaka, and Y Miyazaki
Cost-effectiveness analysis for management of patients with ischemic heart disease.
January 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
K Ogawa, and T Ito, and M Ban, and H Hashimoto, and K Nizoe, and M Mochizuki, and K Sakai, and J Watanabe, and H Kanayama, and K Okumura, and T Sone, and K Imura, and T Uno, and M Shikano, and K Kotaka, and Y Miyazaki
[Comparative effectiveness of psychotropic drugs in patients with chronic ischemic heart disease].
January 1991, Klinicheskaia meditsina,
K Ogawa, and T Ito, and M Ban, and H Hashimoto, and K Nizoe, and M Mochizuki, and K Sakai, and J Watanabe, and H Kanayama, and K Okumura, and T Sone, and K Imura, and T Uno, and M Shikano, and K Kotaka, and Y Miyazaki
Clinical Management of Patients With Stable Ischemic Heart Disease.
April 2023, Cardiology in review,
K Ogawa, and T Ito, and M Ban, and H Hashimoto, and K Nizoe, and M Mochizuki, and K Sakai, and J Watanabe, and H Kanayama, and K Okumura, and T Sone, and K Imura, and T Uno, and M Shikano, and K Kotaka, and Y Miyazaki
Effect of nifedipine and niludipine on myocardial pH in the ischemic canine heart.
March 1986, Archives internationales de pharmacodynamie et de therapie,
K Ogawa, and T Ito, and M Ban, and H Hashimoto, and K Nizoe, and M Mochizuki, and K Sakai, and J Watanabe, and H Kanayama, and K Okumura, and T Sone, and K Imura, and T Uno, and M Shikano, and K Kotaka, and Y Miyazaki
[Effectiveness of the use of rauwolfia derivatives in patients with ischemic heart disease].
June 1975, Vrachebnoe delo,
Copied contents to your clipboard!